Physician profile
Todd E Decker
NPI 1871600676
$1,093.96
in general payments reported to CMS, 2019-2025
17 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $52.16 · 2021: $69.25 · 2022: $107 · 2023: $284 · 2024: $305 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $388.48 | 2019-2024 | Otezla, Repatha |
| Abbvie INC. | $194.23 | 2020-2025 | Qulipta, Ubrelvy |
| Novo Nordisk INC | $92.77 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $63.00 | 2019-2023 | Trelegy Ellipta |
| Pfizer INC. | $60.04 | 2019-2025 | |
| Lilly USA, LLC | $51.74 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $45.40 | 2019-2023 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $36.21 | 2022-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.33 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $24.74 | 2019 | |
| Exact Sciences Corporation | $18.56 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2024 | |
| Merck Sharp & Dohme LLC | $17.31 | 2024 | Gardasil, Vaxelis, Gardasil 9 |
| Baxter Healthcare | $14.60 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Teva Pharmaceuticals USA, INC. | $14.23 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12.63 | 2021 | |
| Biogen, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.